Cohort Study in Fujian Province
Fujian Cohort Study of cARdiomEtabolic Disease and Comorbidity(Fu-CARE)
1 other identifier
observational
150,000
1 country
1
Brief Summary
In this study, Chinese residents aged 35 to 75 years old were recruited from Fujian Province. Physical examination, questionnaire survey and biological sample collection were performed at baseline, and at least 4 years of follow-up were conducted. Information on newly discovered cardiovascular metabolic illnesses and comorbidities was collected during follow-up, and repeated surveys similar to baseline were conducted. To explore the relationship between environment, diet and lifestyle and the risk of cardiovascular metabolic diseases and concomitant disorders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
October 22, 2023
CompletedFirst Posted
Study publicly available on registry
October 26, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedNovember 3, 2023
November 1, 2023
9 years
October 22, 2023
November 1, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Coronary Disease
It is a form of myocardial ischemia (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. At the follow-up, the outcomes of coronary events were acquired. Coronary CTA examination and coronary angiography were the primary measuring modalities.
5 years
Secondary Outcomes (1)
other metabolic diseases
5 years
Eligibility Criteria
A total of 150,000 adult China aged 35 to 74 who have lived in urban or rural areas of Fuzhou, Putian, Quanzhou, Nanping, Xiamen, Zhangzhou, Longyan, Sanming and Ningde in Fujian Province for more than 6 months without cardiovascular disease history and major disability.
You may qualify if:
- Aged 35-75, having lived in Fuzhou, Putian, Quanzhou, Nanping, Xiamen, Zhangzhou, Longyan, Sanming, or Ningde in Fujian Province for more than 6 months.
You may not qualify if:
- Anyone diagnosed with coronary heart disease, stroke, or cancer.
- Anyone with a severe disability who is unable to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fujian Provincial Hospital
Fuzhou, Fujian, 350000, China
Biospecimen
Blood and Urine samples for biochemical tests, biomarker examination and DNA extraction.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Deputy director
Study Record Dates
First Submitted
October 22, 2023
First Posted
October 26, 2023
Study Start
January 1, 2017
Primary Completion
December 31, 2025
Study Completion (Estimated)
December 31, 2026
Last Updated
November 3, 2023
Record last verified: 2023-11